BICYCLE THERAPEUTICS PLCBCYCEarnings & Financial Report
Nasdaq
NextMar 31, 2026
BCYC Q3 2025 Key Financial Metrics
Revenue
$11.7M
Gross Profit
N/A
Operating Profit
$-65.6M
Net Profit
$-59.1M
Gross Margin
N/A
Operating Margin
-558.6%
Net Margin
-503.7%
YoY Growth
338.5%
EPS
$-0.85
Financial Flow
BICYCLE THERAPEUTICS PLC Q3 2025 Financial Summary
BICYCLE THERAPEUTICS PLC reported revenue of $11.7M for Q3 2025, with a net profit of $-59.1M (-503.7% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $11.7M |
|---|---|
| Net Profit | $-59.1M |
| Gross Margin | N/A |
| Operating Margin | -558.6% |
| Report Period | Q3 2025 |
BICYCLE THERAPEUTICS PLC Annual Revenue by Year
BICYCLE THERAPEUTICS PLC annual revenue history includes year-by-year totals (for example, 2024 revenue was $35.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $35.3M |
| 2023 | $27.0M |
| 2022 | $14.5M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3M | $19.5M | $9.4M | $2.7M | $3.7M | $10.0M | $2.9M | $11.7M |
| YoY Growth | 67.4% | 298.9% | -17.9% | -50.0% | -30.4% | -48.9% | -68.8% | 338.5% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $595.3M | $547.1M | $1.06B | $996.7M | $956.9M | $883.9M | $832.2M | $764.0M |
| Liabilities | $224.4M | $191.1M | $183.5M | $165.7M | $163.8M | $143.6M | $163.3M | $145.5M |
| Equity | $370.9M | $356.0M | $873.8M | $831.0M | $793.1M | $740.3M | $668.9M | $618.5M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-47.3M | $-70.9M | $-44.6M | $-39.8M | $-9.4M | $-86.4M | $-72.8M | $-71.2M |